Regeneron Pharmaceuticals Stock Price History
| REGN Stock | USD 658.48 4.14 0.62% |
Below is the normalized historical share price chart for Regeneron Pharmaceuticals extending back to April 02, 1991. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Regeneron Pharmaceuticals stands at 658.48, as last reported on the 24th of March, with the highest price reaching 661.00 and the lowest price hitting 651.13 during the day.
If you're considering investing in Regeneron Stock, it is important to understand the factors that can impact its price. Regeneron Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.0565, which implies the firm had a -0.0565 % return per unit of risk over the last 3 months. Regeneron Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Regeneron Pharmaceuticals' Coefficient Of Variation of (1,461), risk adjusted performance of (0.06), and Variance of 4.01 to confirm the risk estimate we provide.
At this time, Regeneron Pharmaceuticals' Total Stockholder Equity is very stable compared to the past year. As of the 24th of March 2025, Liabilities And Stockholders Equity is likely to grow to about 39.6 B, while Common Stock Shares Outstanding is likely to drop about 76.8 M. . At this time, Regeneron Pharmaceuticals' Price Cash Flow Ratio is very stable compared to the past year. As of the 24th of March 2025, Price Fair Value is likely to grow to 5.14, while Price To Sales Ratio is likely to drop 5.14. Regeneron Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of April 1991 | 200 Day MA 904.7723 | 50 Day MA 690.9362 | Beta 0.268 |
Regeneron |
Sharpe Ratio = -0.0565
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | REGN |
Estimated Market Risk
| 2.01 actual daily | 17 83% of assets are more volatile |
Expected Return
| -0.11 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Regeneron Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Regeneron Pharmaceuticals by adding Regeneron Pharmaceuticals to a well-diversified portfolio.
Price Book 2.4524 | Enterprise Value Ebitda 12.3505 | Price Sales 5.0689 | Shares Float 103 M | Wall Street Target Price 923.0463 |
Regeneron Pharmaceuticals Stock Price History Chart
There are several ways to analyze Regeneron Stock price data. The simplest method is using a basic Regeneron candlestick price chart, which shows Regeneron Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 10, 2025 | 744.83 |
| Lowest Price | March 21, 2025 | 658.48 |
Regeneron Pharmaceuticals March 24, 2025 Stock Price Synopsis
Various analyses of Regeneron Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Regeneron Stock. It can be used to describe the percentage change in the price of Regeneron Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Regeneron Stock.| Regeneron Pharmaceuticals Price Daily Balance Of Power | (0.42) | |
| Regeneron Pharmaceuticals Price Rate Of Daily Change | 0.99 | |
| Regeneron Pharmaceuticals Price Action Indicator | 0.35 |
Regeneron Pharmaceuticals March 24, 2025 Stock Price Analysis
Regeneron Stock Price History Data
The price series of Regeneron Pharmaceuticals for the period between Tue, Dec 24, 2024 and Mon, Mar 24, 2025 has a statistical range of 86.35 with a coefficient of variation of 2.98. The price distribution for the period has arithmetic mean of 696.69. The median price for the last 90 days is 696.16. The company had dividends distributed to its stock-holders on 2025-02-20.| Open | High | Low | Close | Volume | ||
03/24/2025 | 658.00 | 661.00 | 651.13 | 658.48 | ||
| 03/21/2025 | 658.00 | 661.00 | 651.13 | 658.48 | 1,862,085 | |
| 03/20/2025 | 670.00 | 674.83 | 662.33 | 662.62 | 662,950 | |
| 03/19/2025 | 663.67 | 674.55 | 659.03 | 672.36 | 675,029 | |
| 03/18/2025 | 678.00 | 678.27 | 664.30 | 664.96 | 607,935 | |
| 03/17/2025 | 668.15 | 679.83 | 664.68 | 678.42 | 924,686 | |
| 03/14/2025 | 680.61 | 686.91 | 657.00 | 666.87 | 1,305,840 | |
| 03/13/2025 | 687.43 | 698.95 | 677.34 | 680.61 | 781,999 | |
| 03/12/2025 | 709.94 | 712.46 | 683.43 | 689.50 | 807,832 | |
| 03/11/2025 | 745.57 | 747.70 | 712.39 | 718.16 | 1,095,535 | |
| 03/10/2025 | 710.01 | 748.29 | 709.38 | 744.83 | 1,630,587 | |
| 03/07/2025 | 698.63 | 729.75 | 697.01 | 707.51 | 1,082,549 | |
| 03/06/2025 | 683.10 | 700.63 | 683.10 | 698.44 | 866,339 | |
| 03/05/2025 | 673.98 | 692.79 | 673.15 | 687.15 | 828,700 | |
| 03/04/2025 | 688.48 | 697.46 | 673.41 | 675.49 | 1,190,452 | |
| 03/03/2025 | 695.30 | 704.64 | 683.46 | 684.87 | 708,508 | |
| 02/28/2025 | 701.32 | 708.58 | 693.82 | 698.74 | 1,028,626 | |
| 02/27/2025 | 705.90 | 721.00 | 700.67 | 702.78 | 567,783 | |
| 02/26/2025 | 721.29 | 721.41 | 701.07 | 706.94 | 712,900 | |
| 02/25/2025 | 719.99 | 738.78 | 715.50 | 723.47 | 1,049,897 | |
| 02/24/2025 | 703.93 | 725.00 | 700.43 | 713.25 | 896,394 | |
| 02/21/2025 | 697.74 | 704.08 | 693.57 | 700.33 | 727,315 | |
| 02/20/2025 | 688.05 | 703.14 | 686.64 | 696.02 | 533,542 | |
| 02/19/2025 | 674.42 | 687.79 | 674.42 | 684.78 | 638,300 | |
| 02/18/2025 | 678.77 | 689.06 | 674.01 | 679.13 | 826,000 | |
| 02/14/2025 | 677.33 | 683.12 | 670.69 | 672.74 | 623,000 | |
| 02/13/2025 | 664.61 | 676.82 | 661.09 | 673.40 | 604,700 | |
| 02/12/2025 | 659.11 | 670.12 | 655.01 | 663.01 | 1,292,200 | |
| 02/11/2025 | 679.76 | 679.92 | 663.34 | 664.61 | 1,270,800 | |
| 02/10/2025 | 713.53 | 718.86 | 688.04 | 689.47 | 918,500 | |
| 02/07/2025 | 725.53 | 730.48 | 708.64 | 709.09 | 885,700 | |
| 02/06/2025 | 712.50 | 733.33 | 712.50 | 721.14 | 1,116,600 | |
| 02/05/2025 | 707.89 | 728.31 | 699.11 | 715.80 | 1,436,100 | |
| 02/04/2025 | 649.17 | 709.07 | 641.18 | 696.16 | 1,654,500 | |
| 02/03/2025 | 667.94 | 672.79 | 662.58 | 665.99 | 1,009,200 | |
| 01/31/2025 | 676.42 | 687.12 | 671.10 | 672.12 | 943,800 | |
| 01/30/2025 | 687.43 | 688.73 | 673.46 | 682.20 | 771,800 | |
| 01/29/2025 | 685.08 | 696.67 | 681.45 | 686.39 | 522,800 | |
| 01/28/2025 | 681.23 | 689.41 | 677.26 | 685.45 | 640,100 | |
| 01/27/2025 | 675.86 | 697.55 | 675.86 | 683.83 | 1,051,400 | |
| 01/24/2025 | 687.86 | 692.95 | 674.24 | 674.92 | 1,021,800 | |
| 01/23/2025 | 679.67 | 695.30 | 677.41 | 693.75 | 1,145,000 | |
| 01/22/2025 | 688.88 | 698.98 | 676.81 | 679.16 | 945,100 | |
| 01/21/2025 | 686.58 | 692.04 | 680.65 | 686.92 | 1,145,300 | |
| 01/17/2025 | 704.43 | 706.57 | 680.02 | 680.71 | 1,111,900 | |
| 01/16/2025 | 700.14 | 705.63 | 690.44 | 692.34 | 853,900 | |
| 01/15/2025 | 699.71 | 711.69 | 697.30 | 702.53 | 880,400 | |
| 01/14/2025 | 713.09 | 715.06 | 685.12 | 689.98 | 791,700 | |
| 01/13/2025 | 668.38 | 716.45 | 665.39 | 715.98 | 1,406,000 | |
| 01/10/2025 | 720.40 | 723.80 | 690.11 | 695.99 | 1,117,200 | |
| 01/08/2025 | 727.11 | 742.33 | 724.67 | 732.65 | 758,800 | |
| 01/07/2025 | 715.42 | 733.50 | 715.42 | 729.36 | 802,500 | |
| 01/06/2025 | 714.08 | 732.75 | 712.83 | 715.34 | 820,300 | |
| 01/03/2025 | 715.15 | 721.07 | 713.84 | 717.23 | 558,000 | |
| 01/02/2025 | 719.93 | 725.88 | 711.01 | 714.27 | 479,000 | |
| 12/31/2024 | 703.00 | 712.08 | 702.49 | 711.42 | 473,500 | |
| 12/30/2024 | 707.13 | 708.06 | 699.52 | 701.69 | 537,200 | |
| 12/27/2024 | 709.61 | 718.07 | 708.18 | 711.49 | 795,600 | |
| 12/26/2024 | 708.17 | 717.57 | 708.17 | 715.76 | 619,200 | |
| 12/24/2024 | 711.39 | 719.08 | 705.24 | 713.55 | 382,100 | |
| 12/23/2024 | 707.47 | 717.27 | 705.25 | 714.21 | 866,500 |
About Regeneron Pharmaceuticals Stock history
Regeneron Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Regeneron is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Regeneron Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Regeneron Pharmaceuticals stock prices may prove useful in developing a viable investing in Regeneron Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 115.1 M | 76.8 M | |
| Net Income Applicable To Common Shares | 5 B | 5.2 B |
Regeneron Pharmaceuticals Quarterly Net Working Capital |
|
Regeneron Pharmaceuticals Stock Technical Analysis
Regeneron Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Regeneron Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Regeneron Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Regeneron Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Regeneron to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | 0.0051 | |||
| Treynor Ratio | (0.43) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regeneron Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.21) | Earnings Share 38.32 | Revenue Per Share | Quarterly Revenue Growth 0.103 | Return On Assets |
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regeneron Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.